Client Case Study: David Goldband

 

How Iris’ device can be implemented in a work setting and enable the use of computers for employees with post-concussion syndrome

David Goldband is a Senior Manager at Grant Thornton, a leading Canadian accounting, business advisory, and risk management firm. He suffered a concussion playing hockey in February of 2017. Immediately following this injury, his doctor advised him to take time off of work and avoid all stimuli, which could trigger his various symptoms. As the weeks passed, he was slowly finding himself able get out of his condo and be active again; he thought he was finally able to get back to work. It was now spring and he finally made his recovery, or so he thought. While at work, where his job almost exclusively revolves around using a computer, he found his concussion symptoms returning to levels not experienced in weeks. The culprit was his computer; LCD screens flash pixels 60 times a second and are also backlit. The use of his computer triggered symptoms within 10 minutes and it made his return to work almost impossible. Without the use of his computer, he was rendered incapable of doing any work.

Due to this unfortunate but common reality, he was placed on short term disability. Even though he could attend work and read/write on paper, he was unable to use his computer. David is not alone, in the 21st century, most jobs require the use of computers day in, day out. Unfortunately for David, and many other concussion suffers out there, the final barrier to a complete recovery was using his computer screen for a full work day.

“My worst concussion symptom to date has been my severe sensitivity to light, which has made the use of a computer next to impossible.”

David tried everything. At one point, he turned the lights off in his office, turned down the brightness on his computer to its lowest setting, used an app on his computer called F.lux - which changes the contrast on your screen to make it easier to look at - and wore sunglasses, all to no avail. David was stuck and found himself using his computer for a few minutes just to print some emails so that he could keep up-to-date on his work. The situation was frustrating and his recovery was slow. In May, David was looking for a better solution.

This is when David heard about Iris Technologies through a friend who works in the venture capital space and knew of the company. Iris’ product is a secondary computer monitor, which is made from e-paper technology, that connects to an existing laptop and mirrors the display.

After a quick phone call, the founders of Iris delivered him a prototype of their revolutionary, patent-pending e-paper computer monitor. The company’s device had just completed clinical trials, which took place at the Toronto Western Hospital, with leading concussion specialist Dr. Charles Tator. The device received positive results in a clinical setting and the founders were eager to test it in a business setting. The Iris team told David he could use the device for a week free of charge and if he liked it, he could purchase it. After 2 days, David emailed the Iris team and said that the device was immensely valuable and he wanted to buy it. 

“Iris’ secondary computer monitor allowed me to use my computer again and thus go back to work full-time. It allowed me to increase my work day from a couple hours to a full day. I would recommend this device to anyone who has a difficulty viewing a computer screen caused from light sensitivity.”

 Iris’ product is specifically designed for people like David. The product does not refresh like a conventional LCD screen and it is also not backlit. This means that it does not trigger David’s symptoms. Additionally, because it is a monitor, it allows a user to have access to all their existing files, user interface, and programs making it easy to use with no learning curve.

9 weeks later, David is still using Iris’ e-paper computer monitor daily and says it is just as valuable as it was on day 1. The ability to go back to work full time has really helped David feel ‘normal’ again and has made it much easier to progress and manage his recovery.